Study protocol for developing a patient-reported outcome measure for infection screening in hematological patients with secondary immunodeficiency
Jens Lehmann, Jan-Paul Bohn, Claudia Seidl, Samuel M. Vorbach, Wolfgang Willenbacher, Bernhard Holzner, Markus Schuler
Springer Nature ·
2025-10-16
· DOI 10.1186/s12885-025-14996-y
The publisher did not provide an abstract — full text is available via the link below.
Jens Lehmann, Jan-Paul Bohn, Claudia Seidl, Samuel M. Vorbach, Wolfgang Willenbacher, Bernhard Holzner et al. Study protocol for developing a patient-reported outcome measure for infection screening in hematological patients with secondary immunodeficiency. // BMC Cancer. – 2025. – DOI: 10.1186/s12885-025-14996-y. – URL: https://doi.org/10.1186/s12885-025-14996-y
Jens Lehmann, Jan-Paul Bohn, Claudia Seidl, Samuel M. Vorbach, Wolfgang Willenbacher, Bernhard Holzner, & Markus Schuler (2025). Study protocol for developing a patient-reported outcome measure for infection screening in hematological patients with secondary immunodeficiency. BMC Cancer. https://doi.org/10.1186/s12885-025-14996-y
Jens Lehmann, et al. “Study protocol for developing a patient-reported outcome measure for infection screening in hematological patients with secondary immunodeficiency.” BMC Cancer, 2025. doi:10.1186/s12885-025-14996-y.
@article{Lehmann2025,
title = {Study protocol for developing a patient-reported outcome measure for infection screening in hematological patients with secondary immunodeficiency},
author = {Lehmann, Jens and Bohn, Jan-Paul and Seidl, Claudia and Vorbach, Samuel M. and Willenbacher, Wolfgang and Holzner, Bernhard and Schuler, Markus},
journal = {BMC Cancer},
year = {2025},
doi = {10.1186/s12885-025-14996-y},
url = {https://doi.org/10.1186/s12885-025-14996-y}
}